Your browser doesn't support javascript.
loading
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients.
Nakamura, Ryosuke; Arakawa, Noriaki; Tanaka, Yoichi; Uchiyama, Nahoko; Sekine, Akihiro; Mashimo, Yoichi; Tsuji, Keiji; Kagawa, Tatehiro; Sato, Ken; Watanabe, Masaaki; Aiso, Mitsuhiko; Hiasa, Yoichi; Takei, Yoshiyuki; Ohira, Hiromasa; Ayada, Minoru; Tsukagoshi, Eri; Maekawa, Keiko; Tohkin, Masahiro; Saito, Yoshiro; Takikawa, Hajime.
Afiliación
  • Nakamura R; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Arakawa N; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Tanaka Y; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Uchiyama N; Division of Pharmacognosy, Phytochemistry and Narcotics, National Institute of Health Sciences, Kawasaki, Japan.
  • Sekine A; Department of Infection and Host Defense, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Mashimo Y; Department of Public Health, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Tsuji K; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic Survivors Hospital, Hiroshima, Japan.
  • Kagawa T; Division of Gastroenterology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
  • Sato K; Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Watanabe M; Department of Gastroenterology, Kitasato University Medical Center, Kitamoto, Japan.
  • Aiso M; Department of Medicine, Higashisaitama National Hospital, Hasuda, Japan.
  • Hiasa Y; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan.
  • Takei Y; Department of Gastroenterology, Mie University, Tsu, Japan.
  • Ohira H; Department of Gastroenterology, Fukushima Medical University, Fukushima, Japan.
  • Ayada M; Department of Internal Medicine, Kakegawa Higashi Hospital, Kakegawa, Japan.
  • Tsukagoshi E; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Maekawa K; Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyotanabe, Japan.
  • Tohkin M; Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
  • Saito Y; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Takikawa H; Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
Hepatol Res ; 53(5): 440-449, 2023 May.
Article en En | MEDLINE | ID: mdl-36583370
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Hepatol Res Año: 2023 Tipo del documento: Article País de afiliación: Japón